The drugs used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. These inhalers are termed smart inhalers, owing to the sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data acquired by the sensor is shared with the patient and healthcare professionals to track their inhaler usage

The market growth of smart inhalers can be attributed to factors such as the growing geriatric population globally and the rising number of patients suffering from respiratory diseases. According to the Office of Disease Prevention and Health Promotion, more than 25 million in the U.S. are suffering from asthma and 14.8 million adults have been diagnosed with COPD. Also, according to the WHO, smoking is considered to be a primary cause for COPD and more than 1 billion people inhale polluted air exposed to tobacco outdoors. These are among the primary factors that will lead to market growth.

Major Key Players of the Smart Inhalers Market are:
Astra Zeneca plc, GlaxoSmithKline plc, Novartis AG, BoehringerIngelheim International GmbH, Teva Pharmaceutical Industries Ltd., AptarGroup, Inc., Vectura Group plc, Findair Sp. z o. o., H&T Presspart Manufacturing Ltd., and Zeolr Technologies Pvt Ltd,among others.

Download PDF to Know the Impact of COVID-19 on “Smart Inhalers Market” at:

A smart inhaler offers better drug delivery for the treatment of the respiratory tract diseases through noninvasive means to deliver either topically active medications or systemic drugs to target organs. The nose and the lungs are the target organs for the deposition of an aerosol drug. In asthma, drug delivery to the upper airways is needed while for alveolar lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis, it is important to have drug deposition deep within the lungs rather than just the upper airways.Other factors, such as the rising number of digital partnerships between pharmaceutical and software companies to offer smart inhaler devices is expected to offer lucrative growth opportunities to the market. Moreover, technological advancements for the development of innovative products by the key players are also boosting market growth.

The Smart Inhalers Market is segmented on the basis of Product Types, Disease Indication, Distribution Channel and region.

Major Product Types of Smart Inhalers Market covered are:

  • Dry Powder Inhalers
  • Metered Dose Inhalers

Major Disease Indication of Smart Inhalers Market covered are:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma

Major Distribution Channel of Smart Inhalers Market covered are:

However, the lack of awareness among the patients regarding novel technologyisa major factor hamperingmarketgrowth.Additionally, limited product availability in emerging regions is expected to hamper the growth of the target market.

Research objectives:-

– To study and analyze the global Smart Inhalers consumption (value & volume) by key regions/countries, product type and application, history data.

– To understand the structure of the Smart Inhalers market by identifying its various sub-segments.

– Focuses on the key global Smart Inhalers manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.

– To analyze the Smart Inhalers with respect to individual growth trends, future prospects, and their contribution to the total market.

– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Have any query? Inquiry about report at:

Table of Contents

    1. Market Definition
    2. Market Classification
    3. Geographic Scope
    4. Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecast Years – 2020 to 2030
    5. Currency Used
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
    4. Market Estimation Methodology
    5. Data Validation and Triangulation
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
    1. Dry Powder Inhalers
    2. Metered Dose Inhalers
    1. Chronic Obstructive Pulmonary Disease (COPD)
    2. Asthma
    3. Others
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    1. North America Smart Inhalers Market
    2. Europe Smart Inhalers Market
    3. Asia Pacific Smart Inhalers Market
    4. Rest of the World (ROW) Smart Inhalers Market
  9. COMPANY PROFILES                (Business Overview, Products Offered, Financial Performance*, Recent Developments)
    1. AstraZeneca plc
    2. GlaxoSmithKline plc
    3. Novartis AG
    4. BoehringerIngelheim International GmbH
    5. Teva Pharmaceutical Industries Ltd.
    6. AptarGroup, Inc.
    7. Vectura Group plc
    8. Findair Sp. z o. o.
    9. H&T Presspart Manufacturing Ltd.
    10. Zeolr Technologies Pvt Ltd      *Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain

Buy Exclusive Report @

In the end, Smart Inhalers industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.

About Author:

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Tags: Smart Inhalers Market Forecast, Smart Inhalers Market Status, Smart Inhalers Market Sales, Smart Inhalers Market Share, Smart Inhalers Market sIZE, Smart Inhalers Market, Smart Inhalers Market SWOT analysis, Smart Inhalers Sales Market, Smart Inhalers Market Growth

See Campaign:
Contact Information:
Craig Francis (PR & Marketing Manager) HTF Market Intelligence Consulting Private Limited Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 (206) 317 1218 [email protected]

Menafn, iCN Internal Distribution, Research Newswire, English


Contact Information:

Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]